BAX

SEC source: 0001062993-24-003173 · form4.xml · nonDerivative · entry 1

ALMEIDA JOSE E · CIK 0001216761 · Chairman, CEO, President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,376

F1 · shares: Represents shares awarded from the performance share unit award granted on March 3, 2021 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2021 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2021 to December 31, 2023 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended.

SEC source: 0001062993-23-021913 · form4.xml · derivative · entry 3

Grade Joel T. · CIK 0001602507 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,273

Underlying: Common Stock, $1 par value · 102,273 shares

Expires 2033-12-01

F3 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on December 2, 2024, the first anniversary of the grant date.

SEC source: 0001062993-23-021913 · form4.xml · nonDerivative · entry 2

Grade Joel T. · CIK 0001602507 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,177

F2 · shares: The reporting person received a restricted stock unit grant which is scheduled to vest in three equal annual installments beginning on December 2, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

SEC source: 0001062993-23-021913 · form4.xml · nonDerivative · entry 1

Grade Joel T. · CIK 0001602507 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,988

F1 · shares: The reporting person received a restricted stock unit grant which is scheduled to vest in three equal annual installments beginning on December 2, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

SEC source: 0001062993-23-021912 · form4.xml · nonDerivative · entry 1

Stevens Brian · CIK 0001557559 · SVP, CAO & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,532

F1 · shares: In connection with Mr. Steven's appointment as Interim CFO and commensurate with related additional duties, he received a one-time special grant award of restricted stock units which are scheduled to vest on the third anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-23-017699 · form4.xml · nonDerivative · entry 1

Sonig Alok · CIK 0001967368 · EVP, Group President, Pharm

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,512

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 1, 2023 from the settlement of vested restricted stock units granted on September 1, 2022.

SEC source: 0001062993-23-017697 · form4.xml · nonDerivative · entry 1

Borzi James W · CIK 0001495559 · EVP, Chief Supply Chain Office

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,300

F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on September 3, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

SEC source: 0001062993-23-017016 · form4.xml · nonDerivative · entry 1

RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,049

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

SEC source: 0001062993-23-014327 · form4.xml · nonDerivative · entry 1

Ampofo William A. II · CIK 0001983479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,811

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

SEC source: 0001062993-23-012913 · form4.xml · nonDerivative · entry 1

Stevens Brian · CIK 0001557559 · SVP,Interim CFO,CAO&Cntrl

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,982

F1 · shares: In connection with Mr. Steven's appointment to Interim CFO and commensurate with related additional duties, he received a one-time special grant award of restricted stock units which are scheduled to vest on the second anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

SEC source: 0001062993-23-012910 · form4.xml · nonDerivative · entry 1

Rosenbloom David S. · CIK 0001924321 · SVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,645

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on June 1, 2023 from the settlement of vested restricted stock units granted on June 1, 2022.

SEC source: 0001062993-23-012907 · form4.xml · nonDerivative · entry 1

Toth Christopher A. · CIK 0001753950 · EVP, Group Pres, Kidney Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,358

F1 · shares: Mr. Toth received a grant of restricted stock units (RSUs)in connection with his appointment as EVP and Group President, Kidney Care. The RSUs are scheduled to vest in three equal annual installments beginning on June 3, 2024, the first anniversary of the grant date, subject to the terms and conditions set forth in the Baxter International Inc. 2021 Equity Plan. However, this award grant will vest in full if (i) by December 31, 2024, the proposed separation of the Kidney Care business (comprised of the Renal Care and Acute Therapies businesses) as a separately traded company (the "Business Transaction") does not occur; or (ii) in connection with the consummation of the Business Transaction, Mr. Toth is not appointed as Chief Executive Officer of the new company, Kidney Co.

SEC source: 0001062993-23-010219 · form4.xml · nonDerivative · entry 1

WILVER PETER M · CIK 0001234537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,111

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

SEC source: 0001062993-23-010217 · form4.xml · nonDerivative · entry 1

Wilkes David S. · CIK 0001842866 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,034

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

SEC source: 0001062993-23-010216 · form4.xml · nonDerivative · entry 1

Wendell Amy McBride · CIK 0001400568 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,894

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

SEC source: 0001062993-23-010214 · form4.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,130

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

SEC source: 0001062993-23-010213 · form4.xml · nonDerivative · entry 1

Shafer David Brent · CIK 0001728374 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,101

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

SEC source: 0001062993-23-010211 · form4.xml · nonDerivative · entry 1

SCHLICHTING NANCY M · CIK 0001376358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,099

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

SEC source: 0001062993-23-010210 · form4.xml · nonDerivative · entry 1

Oesterle Stephen N. · CIK 0001174532 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,336

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

SEC source: 0001062993-23-010208 · form4.xml · nonDerivative · entry 1

MORRISON PATRICIA · CIK 0001204081 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,984

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

SEC source: 0001062993-23-010206 · form4.xml · nonDerivative · entry 1

Mahoney Michael F · CIK 0001533022 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,692

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

SEC source: 0001062993-23-007482 · form4.xml · nonDerivative · entry 1

Stevens Brian · CIK 0001557559 · SVP. CAO and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,896

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 20, 2023 from the settlement of vested restricted stock units granted on March 20, 2020.

SEC source: 0001062993-23-007483 · form4.xml · derivative · entry 4

STROUCKEN ALBERT P L · CIK 0001205438 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $1 par value · 3,930 shares

Expires 2023-05-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stroucken on February 16, 2023 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Stroucken which were scheduled to expire on May 5, 2023.

SEC source: 0001062993-23-007483 · form4.xml · nonDerivative · entry 2

STROUCKEN ALBERT P L · CIK 0001205438 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,835

SEC source: 0001062993-23-007483 · form4.xml · nonDerivative · entry 1

STROUCKEN ALBERT P L · CIK 0001205438 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,765

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stroucken on February 16, 2023 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Stroucken which were scheduled to expire on May 5, 2023.

SEC source: 0001062993-23-007481 · form4.xml · nonDerivative · entry 1

Rasul Reaz · CIK 0001967379 · EVP, Group Pres, Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,765

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 20, 2023 from the settlement of vested restricted stock units granted on March 20, 2020.

SEC source: 0001062993-23-007480 · form4.xml · nonDerivative · entry 1

Knight Heather · CIK 0001967528 · EVP, Group Pres, Medical

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,110

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 20, 2023 from the settlement of vested restricted stock units granted on March 20, 2020.

SEC source: 0001062993-23-006173 · form4.xml · nonDerivative · entry 1

Stevens Brian · CIK 0001557559 · SVP, CAO and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,058

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 3, 2023 from the settlement of vested restricted stock units granted on March 3, 2021.

SEC source: 0001062993-23-006170 · form4.xml · nonDerivative · entry 1

Knight Heather · CIK 0001967528 · EVP, Group Pres, Medical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,322

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 3, 2023 from the settlement of vested restricted stock units granted on March 3, 2021.

SEC source: 0001062993-23-006172 · form4.xml · nonDerivative · entry 1

Rasul Reaz · CIK 0001967379 · EVP, Group Pres, Healthcare

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,917

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 3, 2023 from the settlement of vested restricted stock units granted on March 3, 2021.

SEC source: 0001062993-23-006070 · form4.xml · nonDerivative · entry 1

Stevens Brian · CIK 0001557559 · SVP, CAO and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,242

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2023 from the settlement of vested restricted stock units granted on March 2, 2022.

SEC source: 0001062993-23-006069 · form4.xml · nonDerivative · entry 1

SACCARO JAMES · CIK 0001593636 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 177,899

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2023 from the settlement of vested restricted stock units granted on March 2, 2022.

SEC source: 0001062993-23-006068 · form4.xml · nonDerivative · entry 1

Rasul Reaz · CIK 0001967379 · EVP, Group Pres, Healthcare

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,066

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2023 from the settlement of vested restricted stock units granted on March 2, 2022.

SEC source: 0001062993-23-006067 · form4.xml · nonDerivative · entry 1

Mason Jeanne K · CIK 0001362109 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,821

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2023 from the settlement of vested restricted stock units granted on March 2, 2022.

SEC source: 0001062993-23-006066 · form4.xml · nonDerivative · entry 1

Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,625

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2023 from the settlement of vested restricted stock units granted on March 2, 2022.

SEC source: 0001062993-23-006065 · form4.xml · nonDerivative · entry 1

Knight Heather · CIK 0001967528 · EVP, Group Pres, Medical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,543

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2023 from the settlement of vested restricted stock units granted on March 2, 2022.

SEC source: 0001062993-23-006064 · form4.xml · nonDerivative · entry 1

Franzi Cristiano · CIK 0001715790 · SVP, President, EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,145

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2023 from the settlement of vested restricted stock units granted on March 2, 2022.

SEC source: 0001062993-23-006063 · form4.xml · nonDerivative · entry 1

Borzi James W · CIK 0001495559 · SVP, Global Supply Chain

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,078

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2023 from the settlement of vested restricted stock units granted on March 2, 2022.

SEC source: 0001062993-23-006062 · form4.xml · nonDerivative · entry 1

ALMEIDA JOSE E · CIK 0001216761 · Chairman, CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 408,453

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2023 from the settlement of vested restricted stock units granted on March 2, 2022.

SEC source: 0001062993-23-005863 · form4.xml · derivative · entry 2

Sonig Alok · CIK 0001967368 · EVP, Group President, Pharm

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,965

Underlying: Common Stock, $1 par value · 63,965 shares

Expires 2033-03-01

F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date.

SEC source: 0001062993-23-005863 · form4.xml · nonDerivative · entry 1

Sonig Alok · CIK 0001967368 · EVP, Group President, Pharm

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,226

F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

SEC source: 0001062993-23-005862 · form4.xml · derivative · entry 2

Rasul Reaz · CIK 0001967379 · EVP, Group Pres, Healthcare

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,965

Underlying: Common Stock, $1 par value · 63,965 shares

Expires 2033-03-01

F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date.

SEC source: 0001062993-23-005862 · form4.xml · nonDerivative · entry 1

Rasul Reaz · CIK 0001967379 · EVP, Group Pres, Healthcare

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,482

F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

SEC source: 0001062993-23-005860 · form4.xml · derivative · entry 2

Knight Heather · CIK 0001967528 · EVP, Group Pres, Medical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,551

Underlying: Common Stock, $1 par value · 89,551 shares

Expires 2033-03-01

F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date.

SEC source: 0001062993-23-005860 · form4.xml · nonDerivative · entry 1

Knight Heather · CIK 0001967528 · EVP, Group Pres, Medical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,611

F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

SEC source: 0001062993-23-005858 · form4.xml · derivative · entry 2

Stevens Brian · CIK 0001557559 · SVP, CAO and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,072

Underlying: Common Stock, $1 par value · 14,072 shares

Expires 2033-03-01

F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date.

SEC source: 0001062993-23-005858 · form4.xml · nonDerivative · entry 1

Stevens Brian · CIK 0001557559 · SVP, CAO and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,660

F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

SEC source: 0001062993-23-005857 · form4.xml · derivative · entry 2

SACCARO JAMES · CIK 0001593636 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,109

Underlying: Common Stock, $1 par value · 92,109 shares

Expires 2033-03-01

F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date.

SEC source: 0001062993-23-005857 · form4.xml · nonDerivative · entry 1

SACCARO JAMES · CIK 0001593636 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 178,961

F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

SEC source: 0001062993-23-005855 · form4.xml · derivative · entry 2

Rosenbloom David S. · CIK 0001924321 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,568

Underlying: Common Stock, $1 par value · 57,568 shares

Expires 2033-03-01

F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date.